SCHEMBL23570971

SCHEMBL23570971

CC(S)C(=O)NC1CNC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
PTGS2 P35354 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
FPR2 P25090 1/20 0.35
CHRNB2 P17787 5/20 0.34
CHRNA4 P43681 5/20 0.34
CHRNB4 P30926 4/20 0.34
CHRNA3 P32297 4/20 0.34
CHRNA7 P36544 4/20 0.34
ACE P12821 2/20 0.33
KMT2A Q03164 1/20 0.32
MME P08473 1/20 0.32
PTGER3 P43115 1/20 0.31
GRM7 Q14831 2/20 0.31
SMYD3 Q9H7B4 1/20 0.31
EPHX1 P07099 2/20 0.31
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10208264 0.83 FPR2 (0.37) FPR2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL3380255 0.80
SCHEMBL13160609 0.79 FPR2 (0.35) ALDH1A1TDP1FPR2CHRNB2CHRNA4
Hydrochloric Acid SCHEMBL7007371 0.78 ARG1 (0.41) LMNAFPR2CHRNB2CHRNA4CHRNB4
Hydrochloric Acid SCHEMBL7007375 0.78 ARG1 (0.41) LMNAFPR2CHRNB2CHRNA4CHRNB4
SCHEMBL19750305 0.76 CHRNB4 (0.43) FPR2CHRNB4CHRNA3KMT2ASMYD3
Hydrochloric Acid SCHEMBL7009720 0.75 ARG1 (0.43) FPR2CHRNB2CHRNA4CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL7009716 0.75 ARG1 (0.43) FPR2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL25161166 0.73 KDM4E (0.37) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL21655188 0.72 FPR2 (0.39) MAPTALDH1A1LMNAPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188789-A1 ISOXAZOLINE DERIVATIVES ELANCO TIERGESUNDHEIT AG 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188789-A1 ISOXAZOLINE DERIVATIVES CYP3A7, CYP4X1, SIRT7 MAPT 3340/4885ALDH1A1 1058/4885LMNA 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.